Seaport Therapeutics, Inc. (SPTX)
$17.15-5.51%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $918M
- Beta
- 1.13
- P/E (TTM)
- -10.53
- Short % float
- 20.85%
- Days to cover
- 8.9
- SI change
- +15.9%
- 1W
- -7.30%
- 1M
- -26.52%
- vs SPY 1W
- -7.72%
- vs SPY 1M
- -28.58%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SPTX?
- LOPJLB’s latest quantitative signal on Seaport Therapeutics, Inc. Common Stock (SPTX) is SELL. Signals are updated daily.
- What market regime is SPTX in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Seaport Therapeutics, Inc. Common Stock (SPTX) do?
- Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circ…